Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats
- 1 July 2007
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 103 (1) , 287-295
- https://doi.org/10.1152/japplphysiol.01509.2005
Abstract
Decreased right as well as left ventricular function can be associated with pulmonary hypertension (PH). Numerous investigations have examined cardiac function following induction of pulmonary hypertension with monocrotaline (MCT) assuming that MCT has no direct cardiac effect. We tested this assumption by examining left ventricular function and histology of isolated and perfused hearts from MCT-treated rats. Experiments were performed on 50 male Sprague-Dawley rats [348 ± 6 g (SD)]. Thirty-seven rats received MCT (50 mg/kg sc; MCT group) while the remainder did not (Control group). Three weeks later, pulmonary artery pressure was assessed echocardiographically in 20 MCT and 8 Control rats. The hearts were then excised and perfused in the constant pressure Langendorff mode to determine peak left ventricular pressure (LVP), the peak instantaneous rate of pressure increase (+dP/d tmax) and decrease (−dP/d tmax), as well as the rate pressure product (RPP). Histological sections were subsequently examined. Pulmonary artery pressure was higher in the MCT-treated group compared with the Control group [12.9 ± 6 vs. 51 ± 35.3 mmHg ( P < 0.01)]. Left ventricular systolic function and diastolic relaxation were decreased in the MCT group compared with the Control group (+dP/d tmax4,178 ± 388 vs. 2,801 ± 503 mmHg/s, LVP 115 ± 11 vs. 83 ± 14 mmHg, RPP 33,688 ± 1,910 vs. 23,541 ± 3,858 beats·min−1·mmHg−1, −dP/d tmax−3,036 ± 247 vs. −2,091 ± 389 mmHg/s; P < 0.0001). The impairment of cardiac function was associated with myocarditis and coronary arteriolar medial thickening. Similarly depressed ventricular function and inflammatory infiltration was seen in 12 rats 7 days after MCT administration. Our findings appear unrelated to the degree of PH and indicate a direct cardiotoxic effect of MCT.Keywords
This publication has 55 references indexed in Scilit:
- Chronic hypoxia induces nonreversible right ventricle dysfunction and dysplasia in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Impact of acute hypoxic pulmonary hypertension on LV diastolic function in healthy mountaineers at high altitudeAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Defective Intracellular Calcium Handling in Monocrotaline-Induced Right Ventricular Hypertrophy: Protective Effect of Long-Term Endothelin-A Receptor Blockade with 2-Benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080)The Journal of Pharmacology and Experimental Therapeutics, 2002
- Dietary β-carotene protects lung and liver parenchyma of rats treated with monocrotalineToxicology, 1999
- Cardiac and Vascular Responses After Monocrotaline-Induced Hypertrophy in RatsJournal of Cardiovascular Pharmacology, 1998
- Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.Journal of Applied Physiology, 1997
- Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertensionThe Journal of Thoracic and Cardiovascular Surgery, 1997
- RIGHT VENTRICULAR FAILURE-INSIGHTS PROVIDED BY A NEW MODEL OF CHRONIC PULMONARY HYPERTENSION1Transplantation, 1997
- Myocardial edema, left ventricular function, and pulmonary hypertensionJournal of Applied Physiology, 1995
- Left ventricular dimensions and function during exercise in dogs with chronic right ventricular pressure overloadThe American Journal of Cardiology, 1984